Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data.

Lerma-Cabrera JM, Carvajal F, Garbutt JC, Navarro M, Thiele TE.

Brain Res. 2020 Mar 1;1730:146628. doi: 10.1016/j.brainres.2019.146628. Epub 2019 Dec 28. Review.

PMID:
31891691
2.

A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection.

Proeschold-Bell RJ, Evon DM, Yao J, Niedzwiecki D, Makarushka C, Keefe KA, Patkar AA, Mannelli P, Garbutt JC, Wong JB, Wilder JM, Datta SK, Hodge T, Naggie S, Fried MW, Muir AJ.

Hepatology. 2019 Dec 5. doi: 10.1002/hep.31058. [Epub ahead of print]

PMID:
31803945
3.

Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States.

Garbutt JC.

Alcohol Alcohol. 2020 Feb 7;55(1):48. doi: 10.1093/alcalc/agz084. No abstract available.

PMID:
31761948
4.

A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.

Walter TJ, Navarro M, Thiele TE, Pedersen C, Kampov-Polevoy A, Garbutt JC.

Alcohol Alcohol. 2020 Feb 7;55(1):56-62. doi: 10.1093/alcalc/agz076.

PMID:
31746964
5.

Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.

Navarro M, Luhn KL, Kampov-Polevoy AB, Garbutt JC, Thiele TE.

Alcohol Clin Exp Res. 2019 May;43(5):783-790. doi: 10.1111/acer.13992. Epub 2019 Mar 19.

PMID:
30817015
6.

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.

de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, Leggio L, Agabio R.

Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708. eCollection 2018. Review.

7.

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtmann M, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L.

Lancet Psychiatry. 2018 Dec;5(12):957-960. doi: 10.1016/S2215-0366(18)30303-1. Epub 2018 Nov 6. No abstract available.

8.

Use of Baclofen for Alcohol Use Disorders in the United States.

Garbutt JC.

Front Psychiatry. 2018 Sep 21;9:448. doi: 10.3389/fpsyt.2018.00448. eCollection 2018. No abstract available.

9.

Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal.

Stephens JR, Moore C, Stepanek KV, Garbutt JC, Starke B, Liles A, Jonas DE.

J Hosp Med. 2018 Apr;13(4):221-228. doi: 10.12788/jhm.2900. Epub 2018 Jan 24.

PMID:
29364992
10.

Screening and Counseling for Unhealthy Alcohol Use in Primary Care Settings.

Jonas DE, Garbutt JC.

Med Clin North Am. 2017 Jul;101(4):823-837. doi: 10.1016/j.mcna.2017.03.011. Review.

PMID:
28577629
11.

Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.

Garbutt JC, Kampov-Polevoy AB, Kalka-Juhl LS, Gallop RJ.

JAMA Psychiatry. 2016 Oct 1;73(10):1056-1063. doi: 10.1001/jamapsychiatry.2016.2157.

PMID:
27627782
12.

Alcohol Use Disorder Treatment: The Association of Pretreatment Use and the Role of Drinking Goal.

Berger L, Brondino M, Fisher M, Gwyther R, Garbutt JC.

J Am Board Fam Med. 2016 Jan-Feb;29(1):37-49. doi: 10.3122/jabfm.2016.01.150143.

13.

Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis.

Jonas DE, Amick HR, Feltner C, Wines R, Shanahan E, Rowe CJ, Garbutt JC.

Pharmacogenomics. 2014 Sep;15(13):1687-700. doi: 10.2217/pgs.14.121. Review.

PMID:
25410894
14.

Medications for alcohol use disorders--reply.

Jonas DE, Feltner C, Garbutt JC.

JAMA. 2014 Oct 1;312(13):1351. doi: 10.1001/jama.2014.10170. No abstract available.

PMID:
25268447
15.

Sweet-liking is associated with transformation of heavy drinking into alcohol-related problems in young adults with high novelty seeking.

Kampov-Polevoy A, Lange L, Bobashev G, Eggleston B, Root T, Garbutt JC.

Alcohol Clin Exp Res. 2014 Jul;38(7):2119-26. doi: 10.1111/acer.12458. Epub 2014 Jun 24.

PMID:
24962796
16.

Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings [Internet].

Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May.

17.

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC.

JAMA. 2014 May 14;311(18):1889-900. doi: 10.1001/jama.2014.3628. Review.

PMID:
24825644
18.

Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence.

Garbutt JC, Greenblatt AM, West SL, Morgan LC, Kampov-Polevoy A, Jordan HS, Bobashev GV.

Addiction. 2014 Aug;109(8):1274-84. doi: 10.1111/add.12557. Epub 2014 May 23. Review.

PMID:
24661324
19.

Intact Hedonic Responses to Sweet Tastes in Autism Spectrum Disorder.

Damiano CR, Aloi J, Burrus C, Garbutt JC, Kampov-Polevoy AB, Dichter GS.

Res Autism Spectr Disord. 2014 Mar;8(3):230-236.

20.

Centrally-mediated sensory information processing is impacted with increased alcohol consumption in college-aged individuals.

Nguyen RH, Gillen C, Garbutt JC, Kampov-Polevoi A, Holden JK, Francisco EM, Tommerdahl M.

Brain Res. 2013 Jan 25;1492:53-62. doi: 10.1016/j.brainres.2012.11.021. Epub 2012 Nov 22.

PMID:
23178333

Supplemental Content

Loading ...
Support Center